Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

The role of iron in type 2 diabetes in humans.

Rajpathak SN, Crandall JP, Wylie-Rosett J, Kabat GC, Rohan TE, Hu FB.

Biochim Biophys Acta. 2009 Jul;1790(7):671-81. doi: 10.1016/j.bbagen.2008.04.005. Epub 2008 May 3. Review.

PMID:
18501198
2.

Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: a prospective cohort study.

Jiang R, Ma J, Ascherio A, Stampfer MJ, Willett WC, Hu FB.

Am J Clin Nutr. 2004 Jan;79(1):70-5.

3.

Factors accounting for high ferritin levels in obesity.

Lecube A, Hernández C, Pelegrí D, Simó R.

Int J Obes (Lond). 2008 Nov;32(11):1665-9. doi: 10.1038/ijo.2008.154. Epub 2008 Sep 9.

PMID:
18779821
4.

[Polycystic ovarian syndrome and diabetes].

Carlsen SM, Salvesen KA, Vanky E, Fougner KJ.

Tidsskr Nor Laegeforen. 2005 Oct 6;125(19):2619-21. Review. Norwegian.

5.

[Should the insulin resistance associated with hepatic iron overload be researched during diabetes mellitus type II?].

Roblin X, Chevassus P, Boudemaghe T, Palayodan A.

Diabetes Metab. 2002 Sep;28(4 Pt 1):335-9. Review. French.

6.

Health implications of iron overload: the role of diet and genotype.

Heath AL, Fairweather-Tait SJ.

Nutr Rev. 2003 Feb;61(2):45-62. Review.

PMID:
12674437
7.

Adipocyte iron regulates adiponectin and insulin sensitivity.

Gabrielsen JS, Gao Y, Simcox JA, Huang J, Thorup D, Jones D, Cooksey RC, Gabrielsen D, Adams TD, Hunt SC, Hopkins PN, Cefalu WT, McClain DA.

J Clin Invest. 2012 Oct;122(10):3529-40. doi: 10.1172/JCI44421. Epub 2012 Sep 10.

8.

Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome.

Dandona P, Dhindsa S, Chaudhuri A, Bhatia V, Topiwala S, Mohanty P.

Curr Mol Med. 2008 Dec;8(8):816-28. Review.

PMID:
19075678
9.

[Genetic iron overloads and hepatic insulin-resistance iron overload syndrome: an update].

Ruivard M.

Rev Med Interne. 2009 Jan;30(1):35-42. doi: 10.1016/j.revmed.2008.05.004. Epub 2008 Jun 26. Review. French.

PMID:
18584923
10.

A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.

Jehn ML, Guallar E, Clark JM, Couper D, Duncan BB, Ballantyne CM, Hoogeveen RC, Harris ZL, Pankow JS.

Am J Epidemiol. 2007 May 1;165(9):1047-54. Epub 2007 Feb 6.

11.

Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.

Holvoet P.

Verh K Acad Geneeskd Belg. 2008;70(3):193-219. Review.

PMID:
18669160
12.

Iron and diabetes risk.

Simcox JA, McClain DA.

Cell Metab. 2013 Mar 5;17(3):329-41. doi: 10.1016/j.cmet.2013.02.007. Review.

13.

Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.

Holst-Schumacher I, Nuñez-Rivas H, Monge-Rojas R, Barrantes-Santamaría M.

Food Nutr Bull. 2009 Jun;30(2):161-70.

PMID:
19689095
14.

[Sleep and metabolic disorders].

Micić DD, Šumarac-Dumanović M, Šušić V, Pejković D, Polovina S.

Glas Srp Akad Nauka Med. 2011;(51):5-25. Review. Serbian.

PMID:
22165724
15.

Metabolic syndrome and the menopause.

Kaaja RJ.

Menopause Int. 2008 Mar;14(1):21-5. doi: 10.1258/mi.2007.007032. Review.

PMID:
18380957
16.

[Metabolic aspects of the polycystic ovary syndrome].

Svacina S.

Vnitr Lek. 2002 Dec;48(12):1142-6. Czech.

PMID:
12642930
17.

Pancreatic beta-cells dysfunction in polycystic ovary syndrome.

Diamanti-Kandarakis E, Xyrafis X, Boutzios G, Christakou C.

Panminerva Med. 2008 Dec;50(4):315-25. Review.

PMID:
19078872
18.
19.

Safety aspects of iron in food.

Schümann K.

Ann Nutr Metab. 2001;45(3):91-101. Review.

PMID:
11423700
20.

[Relationship of dietary iron intake, body iron overload and the risk of metabolic syndrome].

Xiao X, Liu J, Luo B, Feng X, Su Y.

Wei Sheng Yan Jiu. 2011 Jan;40(1):32-5. Chinese.

PMID:
21434307
Items per page

Supplemental Content

Write to the Help Desk